The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 6,691 | 459,836 | SH | OTR | 459,836 | 0 | 0 | ||
89BIO INC | COM | 282559103 | 8,106 | 1,400,000 | SH | OTR | 1,400,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 20,678 | 1,263,930 | SH | OTR | 1,263,930 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 28,312 | 831,495 | SH | OTR | 831,495 | 0 | 0 | ||
ALAUNOS THERAPEUTICS INC | COM | 98973P101 | 2,580 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 6,385 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 24,273 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | ||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 58,665 | 2,084,000 | SH | OTR | 2,084,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 33,163 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 89,043 | 1,303,700 | SH | OTR | 1,303,700 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 37,466 | 1,432,200 | SH | OTR | 1,432,200 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 7,228 | 70,000 | SH | OTR | 70,000 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 3,458 | 2,202,333 | SH | OTR | 2,202,333 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 18,311 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 67,410 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
BELLICUM PHARMACEUTICALS INC | COM NEW | 079481404 | 68 | 56,950 | SH | OTR | 56,950 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 33,792 | 3,200,000 | SH | OTR | 3,200,000 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 5,285 | 686,347 | SH | OTR | 686,347 | 0 | 0 | ||
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 3,405 | 2,014,858 | SH | OTR | 2,014,858 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 5,010 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 18,120 | 275,000 | SH | OTR | 275,000 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 351 | 540,000 | SH | OTR | 540,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 5,030 | 1,251,137 | SH | OTR | 1,251,137 | 0 | 0 | ||
CODIAK BIOSCIENCES INC | COM | 192010106 | 382 | 488,157 | SH | OTR | 488,157 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 6,341 | 425,000 | SH | OTR | 425,000 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 13,770 | 1,074,082 | SH | OTR | 1,074,082 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 101,745 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 23,835 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 3,778 | 2,134,598 | SH | OTR | 2,134,598 | 0 | 0 | ||
EQRX INC | COM | 26886C107 | 4,950 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 19,600 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 7,844 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
GEMINI THERAPEUTICS INC | COM | 36870G105 | 2,132 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 42,792 | 3,571,928 | SH | OTR | 3,571,928 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,960 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 32,866 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 18,539 | 1,935,133 | SH | OTR | 1,935,133 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 41,035 | 2,154,058 | SH | OTR | 2,154,058 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 18,195 | 1,522,559 | SH | OTR | 1,522,559 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 1,126 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | SPON ADS | 589492107 | 1,937 | 2,250,000 | SH | OTR | 2,250,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 38,057 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 6,423 | 698,861 | SH | OTR | 698,861 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 139,680 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 6,540 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 15,960 | 1,224,892 | SH | OTR | 1,224,892 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 23,526 | 1,210,192 | SH | OTR | 1,210,192 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 45 | 266,666 | SH | OTR | 266,666 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 1,986 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 3,373 | 1,054,000 | SH | OTR | 1,054,000 | 0 | 0 | ||
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 4,900 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 37,649 | 3,163,795 | SH | OTR | 3,163,795 | 0 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 19,325 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 101,143 | 1,714,000 | SH | OTR | 1,714,000 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 619 | 209,227 | SH | OTR | 209,227 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 18,189 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
RAIN THERAPEUTICS INC | COM | 75082Q105 | 5,734 | 1,175,000 | SH | OTR | 1,175,000 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 31,136 | 1,239,000 | SH | OTR | 1,239,000 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 48,523 | 2,169,132 | SH | OTR | 2,169,132 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 78,570 | 3,984,264 | SH | OTR | 3,984,264 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 23,398 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 42,841 | 1,094,000 | SH | OTR | 1,094,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 22,108 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 5,386 | 3,284,072 | SH | OTR | 3,284,072 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 97,617 | 3,421,541 | SH | OTR | 3,421,541 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 11 | 66,666 | SH | OTR | 66,666 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 24,875 | 6,871,642 | SH | OTR | 6,871,642 | 0 | 0 | ||
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 5,174 | 892,057 | SH | OTR | 892,057 | 0 | 0 | ||
THIRD HARMONIC BIO INC | COM | 88427A107 | 10,821 | 570,417 | SH | OTR | 570,417 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 56,681 | 6,448,359 | SH | OTR | 6,448,359 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 29,674 | 850,000 | SH | OTR | 850,000 | 0 | 0 | ||
VERU INC | COM | 92536C103 | 28,800 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 21,660 | 600,000 | SH | OTR | 600,000 | 0 | 0 |